Dyspnoea due to vocal fold abduction paresis in anti-MuSK myasthenia gravis.
Sylva
M
M
van der Kooi
A J
AJ
Grolman
W
W
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D004417:Dyspnea / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D007828:Laryngoscopy; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*; D013997:Time Factors; D014826:Vocal Cord Paralysis / Q000150:complications* / Q000175:diagnosis
D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D011950:Receptors, Cholinergic; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases; D011241:Prednisone